| 000 | 01550 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515145401.0 | ||
| 264 | 0 | _c20090323 | |
| 008 | 200903s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009740802366076 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLopez-Gonzalez, R | |
| 245 | 0 | 0 |
_aTreatment of refractory posterior uveitis with infliximab: a 7-year follow-up study. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _c |
||
| 300 |
_a58-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aScleritis _xdrug therapy |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aUveitis, Posterior _xdrug therapy |
| 650 | 0 | 4 |
_aVisual Acuity _xphysiology |
| 700 | 1 | _aLoza, E | |
| 700 | 1 | _aJover, J A | |
| 700 | 1 | _aBenitez Del Castillo, J M | |
| 700 | 1 | _aMendez, R | |
| 700 | 1 | _aHernandez-Garcia, C | |
| 700 | 1 | _aPato, E | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 38 _gno. 1 _gp. 58-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009740802366076 _zAvailable from publisher's website |
| 999 |
_c18452128 _d18452128 |
||